Supreme Court questions NPPA after only ₹1,582.4 crore recovered from overcharging companies
GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains·
Regulatory oversight and enforcement gaps in essential medicine pricing: a GS2 Social Justice and Public Health case study.
Why in news
The Supreme Court questioned the National Pharmaceutical Pricing Authority (NPPA) for its low recovery rate of ₹1,582.4 crore from overcharging companies despite a demand of ₹10,029.8 crore.
Background
As of March 31, 2026, the NPPA recovered only ₹1,582.4 crore out of a total demand of ₹10,029.8 crore from companies overcharging for essential medicines. The matter was heard by a Supreme Court Bench of Justices Vikram Nath and Sandeep Mehta.
Facts for Prelims
- BodyNPPA: National Pharmaceutical Pricing Authority is thebody responsible for capping trade margins on essential medicines.
- FactRecovery amount: ₹1,582.4 crore recovered out of ₹10,029.8 crore demanded as of March 31, 2026.
- PostAishwarya Bhati: Additional Solicitor-General who appeared before the Supreme Court.
Prelims practice question
Which body is responsible for capping trade margins on essential medicines in India?
- (a)National Pharmaceutical Pricing Authority
- (b)Food Safety and Standards Authority of India
- (c)Drug Controller General of India
- (d)Central Drugs Standard Control Organisation
Show answer
Answer: (a) National Pharmaceutical Pricing Authority — The NPPA is the body responsible for capping trade margins on essential medicines.
For Mains
Q. Critically examine the institutional challenges faced by the NPPA in regulating pharmaceutical prices and ensuring the effective recovery of overcharged amounts from private companies.
Dimensions to cover in your answer
- Regulatory bottleneck: Ineffective enforcement mechanisms to monitor and penalize trade margin violations in real-time
- Revenue leakage: Significant gap between demanded and recovered amounts highlighting administrative inefficiencies
- Market distortion: High overcharging by private entities undermining the objective of affordable healthcare for the masses
Keywords: Regulatory oversight · Price capping · Institutional accountability · Public health equity · Enforcement gap
More Social Justice notes
- Pralhad Joshi slams "marks wadi" education system at new CBSE Experience Centre · 28 October 2026
- Kerala government considers ‘Academic Election Commission’ to reform student union elections · 27 October 2026
- Karnataka to establish first Tribal University on 120 acres in Challakere taluk · 27 October 2026
- Assam approves 12% horizontal reservation for eligible ex-Agniveers in specific departments · 27 October 2026
- Gruha Lakshmi scheme disbursed ₹841.14 crore in 2025-26 to help beneficiaries start businesses · 27 October 2026
- IITs fail UGC counsellor mandates as protests seek accountability for Sahil Wakode's death · 27 October 2026
Something wrong, or something missing?
Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.
This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.